| http://www.w3.org/ns/prov#value | - May 21, 2012 ??? HONOLULU- A team of University of Hawaii Cancer Center scientists have created a new type of anti-cancer drug, named BP-1-102 that targets a key protein that triggers the development of many types of cancer including lung, breast, and skin cancers.
|